FOLH1 and neoplasm: Advances in imaging, particularly multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen positron emission tomography (PSMA PET), have improved tumor localization and staging, and are now part of standard diagnostic workflows [9].